NCT00951041View on ClinicalTrials.gov

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 11, 2009

Primary Completion Date

August 30, 2010

Study Completion Date

August 30, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK investigational vaccine GSK2340272A

Two intramuscular injections

BIOLOGICAL

GSK investigational vaccine GSK2340269A

Two intramuscular injections

Trial Locations (3)

01097

GSK Investigational Site, Dresden

01099

GSK Investigational Site, Dresden

01307

GSK Investigational Site, Dresden

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY